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Background: Cardiomyopathy syndrome (CMS) is a severe cardiac disease of Atlantic salmon (Salmo salar) recently
associated with a double-stranded RNA virus, Piscine Myocarditis Virus (PMCV). The disease has been diagnosed in
75-85 farms in Norway each year over the last decade resulting in annual economic losses estimated at up to
€9 million. Recently, we demonstrated that functional feeds led to a milder inflammatory response and reduced
severity of heart lesions in salmon experimentally infected with Atlantic salmon reovirus, the causal agent of heart
and skeletal muscle inflammation (HSMI). In the present study we employed a similar strategy to investigate the
effects of functional feeds, with reduced lipid content and increased eicosapentaenoic acid levels, in controlling
CMS in salmon after experimental infection with PMCV.
Results: Hepatic steatosis associated with CMS was significantly reduced over the time course of the infection in
fish fed the functional feeds. Significant differences in immune and inflammatory responses and pathology in heart
tissue were found in fish fed the different dietary treatments over the course of the infection. Specifically, fish fed
the functional feeds showed a milder and delayed inflammatory response and, consequently, less severity of heart
lesions at earlier and later stages after infection with PMCV. Decreasing levels of phosphatidylinositol in cell
membranes combined with the increased expression of genes related with T-cell signalling pathways revealed new
interactions between dietary lipid composition and the immune response in fish during viral infection. Dietary
histidine supplementation did not significantly affect immune responses or levels of heart lesions.
Conclusions: Combined with the previous findings on HSMI, the results of the present study highlight the
potential role of clinical nutrition in controlling inflammatory diseases in Atlantic salmon. In particular, dietary lipid
content and fatty acid composition may have important immune-modulatory effects in Atlantic salmon that could
be potentially beneficial in fish balancing the immune and tissue responses to viral infections.* Correspondence: laura.martinez@stir.ac.uk
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Cardiomyopathy syndrome (CMS) is a severe cardiac dis-
ease of Atlantic salmon (Salmo salar) recently associated
with a double-stranded RNA virus termed piscine myo-
carditis virus (PMCV) [1]. The disease was first described
and diagnosed in Norway in 1985 [2], and has since also
been diagnosed in the Faroe Islands [3], Scotland [4] and,
possibly, Canada [5]. In 2012, the Norwegian Veterinary
Institute diagnosed the presence of CMS at 89 salmon
farming sites located in the mid-coast of Norway [6].
Early stages of the disease have been reported in adult
Atlantic salmon close to harvest, around 14 to 18 months
after transfer to seawater [7], and so the economic impact
can be considerable [8].
Histopathologically, CMS is characterized by severe in-
flammation and necrosis of the spongy myocardium of
the atrium and ventricle [9], but liver may also be affected
due to the circulatory disturbance associated with the
heart lesions. Mortality is usually moderate although mor-
bidity can be very high with the associated chronic in-
flammatory response lasting for several months. The
pathogenesis of experimentally induced CMS was previ-
ously assessed by transcriptomic profiling using oligo-
nucleotide microarrays in association with pathology
[10,11]. In these studies, cardiac pathology and viral load
were correlated, with an up regulation of T cell response
genes. It appeared that the cellular effector response me-
diated by CD8+ T cells contributed to successful clear-
ance of the virus infection, although it was also correlated
with an up regulation of apoptotic genes, which could
contribute to tissue damage.
The lack of commercial vaccines to CMS currently
makes the use of alternative therapies crucial. Factors
that modulate the inflammatory process might be key to
mitigate the clinical symptoms and improve the perform-
ance of affected fish. The concept of clinical nutrition is
well known in humans [12], and is becoming of increas-
ing interest in aquaculture. Functional feeds are defined
as high-quality feeds that, beyond their nutritional com-
position, are formulated with health promoting features
that could be beneficial in supporting disease resistance
and mitigation of clinical disease symptoms. Thus a clin-
ical nutrition approach using functional feeds potentially
enables a shift away from chemotherapeutic and anti-
biotic treatments, lowering the costs of disease treatment
and management [13]. There are several studies in fish
linking nutrition and immunology, recently reviewed by
Kiron (14). The inclusion in aquaculture feeds of addi-
tives such as prebiotics, probiotics, immunostimulants,
vitamins and nucleotides, is reported to increase growth
and feed conversion efficiency, as well as having positive
effects on the immune system and protection against
bacterial infections [13]. Moreover, macronutrients like
proteins and lipids are reported to play key roles in theregulation of pathways of the immune system and have
been widely studied due to the necessity of the aquafeed
industry to replace dietary fishmeal (FM) and fish oil
(FO) [14].
Polyunsaturated fatty acids (PUFA) are involved in the
regulation of both innate and adaptive immunity, and the
inflammatory response through four potential mecha-
nisms including gene expression, eicosanoid metabolism,
cellular signalling and membrane organization [15]. Spe-
cific transcription factors are activated by a number of
PUFA, long-chain (LC)-PUFA and eicosanoid ligands [16],
and subsequently regulate the expression of genes related
with inflammatory, B-cell and T-cell responses, which play
important roles in viral infections. The roles of PUFA in
cell membrane organization and signalling pathway mech-
anisms have been widely studied in humans [15]. Inhib-
ition of T-cell signalling pathways by PUFA is mainly
linked to the suppression of the elevation of cytoplasmic
calcium concentration through the phosphatidylinositol
(PI) signalling system, which is a key event in T-cell activa-
tion [17]. Eicosanoids are key mediators of inflammation
and the regulation of T and B lymphocyte functions. Ara-
chidonic acid (20:4n-6; ARA) and eicosapentaenoic acid
(20:5n-3; EPA), released from membrane phospholipids
through the action of phospholipases, are converted to
pro- or anti-inflammatory eicosanoids, respectively and,
although the enzymes of eicosanoid metabolism have a
preference for ARA, increased levels of EPA in the mem-
branes of immune cells inhibit the production of pro-
inflammatory eicosanoids [18]. Studies have demonstrated
that LC-PUFA have similar roles in immune modulation
in fish. Substitution of dietary FO by vegetable oil (VO),
with consequent reduction in the ratio of n-3/n-6 LC-
PUFA, promotes the synthesis of pro-inflammatory eicos-
anoids [19,20], and alters humoral immunity and the ex-
pression of pro-inflammatory cytokine genes [21]. Most
studies have been performed in vitro [22-24], and so little
is known about the roles of LC-PUFA during viral infec-
tions in fish.
In a previous study, the use of functional feeds led to a
milder inflammatory response and reduced severity of
heart lesions in salmon experimentally infected by Atlan-
tic salmon reovirus (ASRV), the causal agent of heart and
skeletal muscle inflammation (HSMI) [25]. As both HSMI
and CMS have similar symptoms, we have employed a
similar strategy in the present study to investigate the ef-
fects of functional feeds in controlling CMS. The func-
tional feeds contained increased EPA levels, from 3.6% in
a reference feed to 14%, and reduced dietary lipid, from
31% to 18% in the functional feeds. Supplementation of
histidine was also assessed in one of the functional feeds
as this amino acid and related compounds, such as N-α-
acetyl-histidine (NAH), have important roles in muscle
pH buffering [26,27] and tissue antioxidant systems
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cardio-protective role in human studies, being potentially
beneficial in the alleviation of oxidative stress associated
with viral diseases [30]. Thus, we hypothesized that diet-
ary supplementation of this amino acid could have a po-
tentially beneficial effect in fish suffering CMS.
Fish were fed the experimental feeds for 8 weeks prior
to infection by PMCV and throughout the study post-
infection. The incorporation of LC-PUFA into membrane
phospholipids of heart, the main organ affected by the
disease, was assessed, and both heart and liver tissues
were subjected to histological evaluation. The inflamma-
tory and immune status in heart tissue was assessed after
infection by determining gene expression through oligo-
nucleotide microarray analysis.
Results
Lipid and fatty acid composition of heart tissue
The total lipid content of heart tissue was unaffected
by dietary treatment and did not show any significant
changes over the course of infection (Table 1). Propor-
tions of triacylglycerol (TAG) were lower and those of
total PL and the major PL classes, phosphatidylcholine
(PC) and phosphatidylethanolamine (PE), significantly
higher in heart tissue of fish fed the functional feeds
compared with fish fed the REF diet (2-way ANOVA p-
value diet, < 0.05) (Figure 1). These differences were
particularly apparent at the end of the pre-feeding
phase and, after PMCV infection, PL levels generally
decreased, significantly for phosphatidylinositol (PI)
and phosphatidylserine (PS), over the course of the
infection.
The fatty acid compositions of total PL of heart tis-
sue of fish fed the functional feeds reflected the com-
position of the diets showing different proportions of
the LC-PUFA that could potentially influence the im-
mune response [31] (Table 1). Thus, the proportions of
EPA, ARA and the EPA/ARA ratio were significantly
higher in fish fed the functional feeds compared to fish
fed the REF diet (P value diet, <0.05). However, levels
of docosahexaenoic acid (22:6n-3; DHA) were similar
between the different dietary groups, which was con-
sistent with our previous study using similar feeds in
which tissue levels of DHA were more conserved des-
pite differences in the composition of the diets [25].
The proportions of the inflammation-related LC-PUFA
in heart total PL changed during the time course of the
infection but were similar in fish fed the three dietary
treatments (Table 1). The changes in ARA post-
infection were not significant, but the proportions of
EPA and DHA were significantly higher at 6-wpc com-
pared with pre-challenge. After 6-wpc, levels of DHA
progressively decreased during the time-course of the
infection but proportions of EPA were significantlyhigher at 10-wpc. As a consequence of the latter, the
EPA/ARA ratio in heart total PL was also higher in all
dietary treatments at 10-wpc. There were no differ-
ences in the EPA/ARA ratio in heart PL between fish
fed the different diets in the later stages of the
infection.
Heart and liver tissue histopathology
Histological changes were consistent with CMS and first
observed in the atrium at 6-wpc (Figure 2), characterized
by focal infiltration of inflammatory cells dominated by
lymphocytes. A degenerative process associated with the
inflammatory changes was also observed in cardiomyo-
cytes of the atrium. The most marked increase in histo-
pathological scores was found in the ventricle of fish
from all the dietary groups from 6- to 8-wpc. These
changes were typified by multifocal infiltration of inflam-
matory cells, dominated by lymphocytes and macro-
phages, and concomitant degeneration and necrosis of
myocytes. Another typical finding was hyperplasia of
endothelial cells in inflamed areas. Inflammatory changes
were greatest in the atrium from 6- to 8-wpc and signifi-
cantly higher for all groups at both time points. By 10-
wpc, the inflammatory changes and myocyte necrosis
had levelled off in all groups, and was not different from
8-wpc. At 12- and 14-wpc there was a moderate decline
in inflammatory scores (Figure 2).
Differences between dietary groups were found mainly
in the early stages of the disease, at 6- and 8-wpc. Fish
fed both functional feeds showed significantly lower his-
toscores in the atrium at both 6- and 8-wpc compared to
fish fed the REF diet (Figure 2). Lesions in the ventricle
were also lower in fish fed the functional feeds, being sig-
nificant in both dietary groups at 8-wpc but only for the
fish fed with the CMS2 diet at 6-wpc. There were no dif-
ferences in inflammation in either part of the heart be-
tween dietary groups at 10- and 12-wpc. At the end of
the trial, 14-wpc, lesions in the atrium were not signifi-
cantly different between groups, although fish fed with
CMS2 had lower histoscores compared with the other
groups. In ventricle, fish fed both functional feeds
showed lower histoscores although they were not signifi-
cantly different (Figure 2).
The liver histology scores, based on the degree of steato-
sis were interpreted as vacuole-formation in hepatocyte
cytoplasm characterized by both micro- and macro-
vesicular lesions. There were clear differences between the
fish fed the functional feeds and fish fed the REF diet at all
samplings points post-challenge, with the latter group pre-
senting higher micro- and macro-vesicular steatosis. Se-
verity of the liver histopathology was significantly higher
at the beginning of the infection and greater at the end of
the challenge (12- and 14-wpc) in salmon fed the REF diet
compared to fish fed the two functional feeds (Figure 3).
Table 1 Fatty acid compositions (percentage of total fatty acids) of total phospholipids of heart tissue from fish fed the reference (REF) and functional (CMS1
and CMS2) feeds at different times before (PreCh) and after (6, 8, 10, 12 and 14 weeks) infection with PMCV
PreCh 6 wpc 8 wpc 10 wpc 12 wpc 14 wpc TWO WAY ANOVA
P-value
REF CMS1 CMS2 REF CMS1 CMS2 REF CMS1 CMS2 REF CMS1 CMS2 REF CMS1 CMS2 REF CMS1 CMS2 Diet Week Diet*Week
Saturated 25.9 ±
0.8
31.2 ±
0.9
31.9 ±
0.8
27.6 ±
0.8
29.7 ±
0.7
30.1 ±
0.6
27.2 ±
0.6
29.9 ±
0.7
29.2 ±
0.5
27.1 ±
0.5
29.5 ±
0.3
29.9 ±
0.5
27.6 ±
1.5
30.6 ±
1.4
31.2 ±
1.0
27.9 ±
0.5
31.3 ±
0.4
30.4 ±
0.7
0.000 0.005 ns
18:1n-9 13.2 ±
0.6
7.4 ±
0.6
6.8 ±
0.3
9.5 ±
0.4
6.8 ±
0.2
7.2 ±
0.4
10.1 ±
0.3
7.2 ±
0.2
8.0 ±
0.4
10.2 ±
0.8
7.5 ±
0.6
7.5 ±
0.7
11.0 ±
1.5
7.3 ±
0.1
7.6 ±
0.3
11.5 ±
0.6
7.5 ±
0.2
7.3 ±
0.5
0.000 0.003 0.003
Monounsat 24.6 ±
2.6
15.4 ±
0.9
15.3 ±
0.7
18.0 ±
1.0
14.7 ±
0.8
15.1 ±
1.1
19.5 ±
0.7
14.9 ±
0.7
16.8 ±
0.9
18.9 ±
1.6
15.6 ±
1.3
15.8 ±
1.9
20.4 ±
3.0
15.5 ±
0.4
15.8 ±
0.7
21.5 ±
1.4
15.7 ±
0.6
15.5 ±
1.0
0.000 0.033 0.065
18:2n-6 4.3 ±
0.4
1.9 ±
0.1
1.7 ±
0.1
3.3 ±
0.1
1.7 ±
0.1
1.7 ±
0.1
3.4 ±
0.1
1.8 ±
0.1
2.1 ±
0.2
3.3 ±
0.2
1.8 ±
0.2
1.8 ±
0.1
3.4 ±
0.4
1.7 ±
0.0
1.7 ±
0.1
3.5 ±
0.2
1.8 ±
0.1
1.8 ±
0.1
0.000 0.008 0.021
20:3n-6 0.6 ±
0.0
0.1 ±
0.0
0.2 ±
0.0
0.6 ±
0.0
0.2 ±
0.0
0.2 ±
0.0
0.6 ±
0.0
0.3 ±
0.0
0.3 ±
0.0
0.5 ±
0.0
0.3 ±
0.0
0.3 ±
0.0
0.4 ±
0.0
0.3 ±
0.0
0.3 ±
0.0
0.4 ±
0.0
0.2 ±
0.0
0.2 ±
0.0
0.000 0.000 0.000
20:4n-6 1.4 ±
0.0
1.7 ±
0.1
1.6 ±
0.1
1.5 ±
0.1
1.7 ±
0.1
1.7 ±
0.1
1.5 ±
0.0
1.7 ±
0.1
1.6 ±
0.0
1.4 ±
0.1
1.7 ±
0.0
1.7 ±
0.2
1.3 ±
0.1
1.8 ±
0.1
1.7 ±
0.1
1.4 ±
0.1
1.8 ±
0.1
1.8 ±
0.1
0.000 0.056 0.002
n-6 PUFA 7.3 ±
0.4
4.7 ±
0.2
4.5 ±
0.1
6.2 ±
0.1
4.5 ±
0.1
4.5 ±
0.1
6.2 ±
0.1
4.7 ±
0.0
4.8 ±
0.2
6.1 ±
0.2
4.8 ±
0.2
4.7 ±
0.1
6.0 ±
0.4
4.6 ±
0.1
4.6 ±
0.1
6.4 ±
0.2
5.0 ±
0.1
4.9 ±
0.1
0.000 0.000 0.000
18:3n-3 1.5 ±
0.1
0.5 ±
0.1
0.4 ±
0.0
1.1 ±
0.0
0.4 ±
0.0
0.4 ±
0.0
1.2 ±
0.1
0.5 ±
0.0
0.6 ±
0.1
1.3 ±
0.1
0.5 ±
0.0
0.5 ±
0.0
1.3 ±
0.2
0.4 ±
0.0
0.4 ±
0.0
1.4 ±
0.0
0.5 ±
0.0
0.5 ±
0.0
0.000 0.000 0.001
20:5n-3 6.3 ±
0.3
9.7 ±
0.3
9.6 ±
0.4
7.7 ±
0.3
10.6 ±
0.3
10.4 ±
0.3
8.0 ±
0.3
10.5 ±
0.2
10.2 ±
0.3
8.4 ±
0.4
11.3 ±
0.4
10.8 ±
0.4
8.0 ±
0.1
10.9 ±
0.6
10.4 ±
0.2
7.7 ±
0.3
10.3 ±
0.4
11.0 ±
0.6
0.000 0.000 0.038
22:6n-3 31.5 ±
1.4
33.8 ±
1.3
33.9 ±
1.5
35.8 ±
1.4
35.3 ±
0.9
34.8 ±
1.5
34.6 ±
0.7
34.8 ±
0.5
33.6 ±
0.7
34.5 ±
0.8
33.2 ±
1.9
33.6 ±
1.5
33.4 ±
2.7
32.9 ±
1.2
32.8 ±
1.4
31.7 ±
1.5
32.4 ±
0.5
32.7 ±
1.0
ns 0.000 ns
n-3 PUFA 42.0 ±
1.4
48.3 ±
1.7
48.0 ±
1.8
47.4 ±
1.2
50.7 ±
0.8
50.0 ±
1.6
46.8 ±
0.8
50.3 ±
0.8
48.8 ±
0.8
47.3 ±
1.2
49.8 ±
1.7
49.4 ±
1.8
45.7 ±
2.5
48.9 ±
1.8
48.1 ±
1.5
43.8 ±
1.6
47.5 ±
0.5
48.8 ±
1.6
0.000 0.000 ns
PUFA 49.3 ±
0.8
53.0 ±
0.9
52.6 ±
0.7
53.7 ±
1.1
55.2 ±
0.8
54.5 ±
1.6
53.0 ±
0.8
55.0 ±
0.8
53.6 ±
0.6
53.4 ±
1.0
54.6 ±
1.5
54.0 ±
1.8
51.7 ±
2.2
53.5 ±
1.7
52.6 ±
1.5
50.2 ±
1.5
52.5 ±
0.6
53.7 ±
1.5
0.000 0.000 ns
EPA/ARA 4.6 ±
0.2
5.8 ±
0.4
5.8 ±
0.3
5.2 ±
0.2
6.3 ±
0.2
6.3 ±
0.3
5.5 ±
0.2
6.1 ±
0.0
6.5 ±
0.3
6.0 ±
0.2
6.6 ±
0.1
6.6 ±
0.4
6.1 ±
0.5
6.2 ±
0.3
6.3 ±
0.1
5.7 ±
0.1
5.7 ±
0.4
6.0 ±
0.3
0.000 0.000 0.001
n-3/n-6 5.7 ±
0.2
10.3 ±
0.5
10.6 ±
0.3
7.6 ±
0.3
11.2 ±
0.3
11.2 ±
0.5
7.5 ±
0.2
10.6 ±
0.2
10.1 ±
0.5
7.7 ±
0.4
10.4 ±
0.8
10.6 ±
0.3
7.7 ±
1.0
10.6 ±
0.6
10.5 ±
0.3
6.9 ±
0.4
9.6 ±
0.1
10.1 ±
0.5
0.000 0.000 0.066
Total lipid 2.8 ±
0.3
3.5 ±
0.2
3.6 ±
0.2
3.32 ±
0.2
3.34 ±
0.2
3.49 ±
0.2
3.8 ±
0.4
3.34 ±
0.2
3.63 ±
0.6
3.84 ±
0.3
3.55 ±
0.2
3.58 ±
0.3
3.85 ±
0.2
3.56 ±
0.1
3.46 ±
0.1
3.81 ±
0.3
3.44 ±
0.5
3.46 ±
0.4
ns ns ns
ARA, arachidonic acid; DHA, docosahexaenoic acid (DHA); EPA, eicosapentaenoic acid; PUFA, polyunsaturated fatty acid.
Diet*Week indicates the p value of the interaction of those two factors in the 2-way ANOVA statistical analysis.
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Figure 1 Proportions of lipid classes in total lipid of heart tissue from fish fed the reference (REF) and functional (CMS1 and CMS2)
feeds at different times before (PreCh) and after (6, 8, 10, 12 and 14 weeks) infection with PMCV. Data were analysed by 2-way ANOVA
with “time-course” and “diet” as the two factors. Different letters above time-points indicate significant differences between time-points over the
time-course of the infection. The factor diet showed significant differences in PC, PE, total phospholipids and TAG (not indicated). PC,
phosphatidycholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; TAG, triacylglycerol.
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Viral load was similar for the three dietary groups at 6-
wpc, however by 8-wpc, although individual variation in
viral RNA was observed, heart viral load was higher in
fish fed the REF diet compared with fish fed the func-
tional feeds, significantly so in the case of fish fed CMS2
(Figure 4).
Cardiac transcriptomic responses
Time-course of disease
Comparison of gene expression changes in fish fed the
REF diet over the course of infection (6-, 8- and 14-wpc)
relative to pre-challenge levels showed highly co-
ordinated up-regulation of genes involved in immune
pathways (Figure 5); data for representative genes included
in Figure 5 are in Table 2. The antiviral and IFN response
(62 features), mainly represented by previously annotated
virus-responsive genes [32], showed highest expression at
6- and 8-wpc that levelled off by 14-wpc. The largest
group of genes associated with T cell responses (99features) reached peak levels by 8-wpc coinciding with the
peak of cardiac histoscores. A similar profile was observed
for genes involved in antigen presentation via major histo-
compatibility complexes (MHC class I and II), however
their induced expression remained stable to 14-wpc. The
B cell response, represented by various immunoglobulins
(26 features), showed increasing expression from 6- and
8-wpc until peak levels at 14-wpc. Recovery in cardiac
histopathology by 14-wpc was consistent with significantly
reduced expression of several inflammatory markers, such
as granzyme A, serum amyloid A, TNF decoy receptor
(tnfrsf6b) and neutrophil cytosolic factor 4. It is also
noteworthy that negative immune regulators such as sup-
pressor of cytokine signaling 3 and lymphocyte antigen
75/cd205 were induced by 14-wpc.
Effects of functional feeds pre- and post-challenge
Effects on immune responses
A large fraction of differentially expressed genes encoded
proteins of the immune system and genes from several
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Figure 2 Histopathology results in heart tissue. Figures on the left are representing incidence (percentage of fish sampled) and severity of
histopathology (based on the criteria described in methods) in both parts of the heart, atrium and ventriculum at 6-, 8-, 10-, 12-, 14-weeks
post-challenge in fish fed the Reference diet (R), and the two functional feeds CMS1 (1) and CMS2 (2). Figures on the right are representing the
statistical analysis of the atrium and ventriculum histoscores. Estimated effects of CMS1 and CMS2 diets in comparison to the REF diet by
sampling weeks. Negative estimates mean there are lower scores and positive that there are higher scores than for the REF dietary group. Error
bars denote approximate 95% confidence limits.
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the course of the infection (Figure 6; Additional file 1:
Table S1); results for selected genes are given in Table 3.
Overall, the functional feeds resulted in down-regulated
levels of immune genes, suggestive of immune suppressive
actions (Figure 7). At pre-challenge this was most signifi-
cant for antiviral and IFN responses, which showed re-
duced expression in fish fed CMS1 and CMS2 compared
to fish fed the REF diet (Figure 7). This down-regulation
was also significant at 8-wpc, although with lower magni-
tude, and this coincided with the most significant reduc-
tion in ventricle histoscore in fish fed the functional feeds
(Figure 2). Among antiviral and IFN genes, the largest ex-
pression differences were found in genes known for potent
responses to viruses, such as very large inducible GTPase
1, IFN inducible MX protein and receptor-transporting
protein 3. Notable exceptions were two genes encoding
IFN regulatory factors – IRF4 and IRF7 – that had from2.6 to 4.4-fold higher expression before challenge in sal-
mon fed with the functional feeds compared to the REF
diet. The expression profiles of immunoglobulin (Ig) genes
most likely reflected the influx and amount of B cells in
the heart. Fish fed the functional feeds had slightly lower
abundance of 28 Ig transcripts before challenge that were
further reduced by 6-wpc, followed by normalized levels
from 8- to 14-wpc. The most striking immunosuppressive
effect of functional feeds was observed for T cell response
genes, as suggested by significantly reduced expression of
64 transcripts at pre-challenge, 6- and 8-wpc, and moder-
ately lower reduction at 14-wpc. Down-regulation of CD8
beta, granzyme A/K and IFN gamma could imply that a
large fraction of this population was represented by cyto-
toxic T cells. Granzyme A and TNF decoy receptor tnfrsf6b,
which were also down-regulated by the functional feeds,
showed strongest correlation with heart histopathology
level in a previous CMS study [11].
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Figure 3 Histopathology results in liver tissue. Figure on the left is representing incidence (percentage of fish sampled) and severity of
histopathology (based on the criteria described in methods) at 6-, 8-, 10-, 12-, 14-weeks post-challenge in fish fed the Reference diet (R), and the
two functional feeds CMS1 (1) and CMS2 (2). Figure on the right is representing the statistical analysis of liver histoscores. Estimated effects of
CMS1 and CMS2 diets in comparison to the REF diet by sampling weeks. Negative estimates mean there are lower scores and positive that there
are higher scores than for the REF dietary group. Error bars denote approximate 95% confidence limits.
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Differences in expression of genes involved in lipid me-
tabolism that could potentially modulate the immune re-
sponse were also observed over the course of the
infection (Additional file 1: Table S1). Among the signifi-
cantly relevant genes were those related to the PI signal-
ling system (Figure 8) and the biosynthesis of LC-PUFA.
In general, the expression of the genes related to the PI
signalling pathway was not correlated with tissue path-
ology or the expression of immune-related genes, asFigure 4 Viral load in heart tissue of the different dietary
groups at 6- and 8-weeks post-challenge. Viral load was
determined by quantitative real-time PCR analysis of Piscine
Myocarditis Virus. Results are presented as CT values (normalized) as
a basis for showing the relative level of virus expression (n = 6)
Levels of significant differences (t-test) were calculated using the
relative expression software tool (REST 2009).there was higher activation of those genes at all sampling
points after PMCV infection in fish fed the functional
feeds compared with fish fed the REF diet. Of the lipid
metabolism genes (Additional file 1: Table S1), the most
significant effect was detected with probes for the delta-
6 fatty acyl desaturase (Fadsd6) gene (Figure 9A). Differ-
ences between the three dietary groups were most prom-
inent at 6-wpc, when expression of this gene was higher
in the fish fed with the functional feeds compared with
fish fed the REF diet. However, these differences ap-
peared to correlate more with heart tissue pathology ra-
ther than diet as the expression of this gene significantly
decreased over the time course of the infection in all
dietary groups (Figure 9B).
Discussion
The present study demonstrated the potential of dietary
immunomodulation for reducing the pathological out-
come of virus-associated heart diseases in salmon. Spe-
cifically, increased dietary levels of EPA and reduced
lipid content were associated with altered expression of
genes related with the immune response after an infec-
tion with PMCV, significantly reduced pathology in heart
and liver tissue, and reduced viral loads at 8 wpc when
there was a peak in heart pathology. In contrast, the
addition of histidine did not appear to improve the per-
formance of the fish as the level of heart lesions and the
expression of genes related with the immune response
were not further reduced in fish fed the histidine supple-
mented diet.
The specific mechanism explaining the potential role
(s) of reduced dietary lipid content in the effects of the
-1
0
1
2
3
4
5
6 8 14
a
b
b
-1
0
1
2
3
4
5
6 8 14
-1
0
1
2
3
6 8 14
a
ba
-1
0
1
2
3
4
5
6
7
8
6 8 14
Antiviral and IFN response (61 features) Antigen presentation (25 features) 
B cell response (26 features) T cell response (99 features) 
Lo
g 2
 
ex
pr
es
si
o
n
 r
at
io
Weeks post PMCV infection
a
ba
a
b
c
Figure 5 Time-course of four immune pathways to PMCV infection examined with microarray in salmon fed with REF diet. Boxes show
median log2 gene expression ratio (total number of features for each pathway indicated in panel header) between pre-challenge and time points
post infection, with the 25th (dark grey) and 75th (light gray) percentile, and whiskers indicate minimum and maximum values. Letters indicate
significant differences between time points (p < 0.05, Student t-test).
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http://www.biomedcentral.com/1471-2164/15/462functional feeds is not clearly established [25,33]. Previous
studies on HSMI showed that there was reduced lipid de-
position (steatosis) in livers of fish fed the functional feeds
with lower lipid content at initial stages of the disease and
the steatosis was usually more frequent when the severity
of the heart lesions was high [33]. Thus, there was some
association between liver lipid metabolism and on-going
viral infection, although earlier studies had found no cor-
relation between the severity of heart and liver lesions
during different stages of HSMI disease, associating the
liver lesions to the circulatory disturbances as a conse-
quence of heart pathology [34]. Therefore, although the
precise mechanism of the reduced liver steatosis index at
initial stages in fish fed the functional feeds was not iden-
tified in detail, lower dietary lipid was a likely contributing
factor [33]. The functional feeds used in the present study
were beneficial for the prevention of liver pathology asso-
ciated with CMS. Fish fed functional feeds showed lower
liver histoscores over the whole course of the infection,
significantly so at 6-, 12- and 14-wpc, possibly due to the
lower dietary lipid content that could reduce liver lipid
metabolism when circulatory disturbances are potentially
affecting this organ.
Levels of EPA and ARA, and the EPA/ARA ratio, in
heart tissue PL were significantly altered by the functionalfeeds, and hence one of the main strategies of the experi-
mental design was achieved. Specifically, the potential bio-
availability of EPA and its proportion relative to ARA was
always higher over the time-course of the infection in fish
fed the functional feeds compared with fish fed the REF
diet. Interestingly, the use of Southern hemisphere FO in
the functional feeds in the present trial also increased the
level of ARA in heart tissue PL and thus the EPA/ARA ra-
tio was actually lower than in heart tissue of fish in the
previous trial on HSMI [25]. The relative proportions of
ARA and EPA remained generally constant during the
time-course of the PMCV infection although, as described
above for DHA, there were increased levels of both ARA
and EPA when, according to gene expression analysis,
there was activation of the immune response. However,
this was only significant for EPA, possibly reflecting the
higher absolute levels of EPA generated by the functional
feeds in the present trial.
As previously described in humans [35] and fish
[21,36,37], the fatty acid compositions of membrane PL
play a critical role in the regulation of the innate and
adaptive immune response. Fatty acids such as ARA,
EPA and DHA, released from membrane PL through
the action of phospholipases, modulate the immune
response not only through eicosanoids, but also by
Table 2 Examples of immune genes induced in CMS challenged salmon. Data are challenge to pre-challenged
expression ratios (fold changes) on the fish fed with the REF diet
Genbank Gene, symbol 6 wpc 8 wpc 14 wpc
Antigen presentation and VRG
U20945 MHCII beta chain 4.80 10.91 8.10
DY713447 CD40 1.73 3.06 3.26
AF508864 MHC class I antigen 3.60 6.17 10.80
DW538400 IFN-induced protein 44, ifit44 6.93 24.09 6.77
117530907 Barrier-to-autointegration factor, bainf 13.20 14.39 2.96
EG795847 GTPase IMAP family member 7, gimap7 3.65 9.05 3.44
T cells
AJ841811 Interferon gamma, ifng 3.60 8.03 1.29
DY710412 Granzyme A, graa 21.78 131.75 6.62
NM_0011235 CD8 alpha 3.13 12.06 6.44
213070237 CD45 7.11 10.20 11.83
EG819885 Cytotoxic T-lymphocyte protein 4, ctla 5.18 14.95 3.04
Inflammatory markers, regulators
CX032230 TRAF interacting protein, traip 1.26 2.32 3.27
117427898 Chemokine CCL-C24 2.98 10.93 16.14
AJ517803 TNFR associated factor 3, traf3 2.70 1.29 3.15
CU652893 Serum amyloid A5, saa 3.11 1.76 1.53
EG881931 TNF decoy receptor, tnfrsf6b 3.54 10.64 1.41
EG904168 IL1b 2.48 2.66 2.84
117496064 Neutrophil cytosolic factor 4, ncl4 1.43 2.64 0.94
213077403 TNF alpha-induced protein 2, tnfaip2 3.39 5.28 3.95
S48406409 Lymphocyte antigen 75, Ly75/CD205 2.21 2.64 9.20
213081931 Helicase lymphoid-specific, hells 1.03 6.06 6.52
DW578491 Suppressor of cytokine signaling 3b, socs 3b 1.34 1.42 3.41
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Figure 6 Effect of functional feeds on gene expression in heart tissue of Atlantic salmon examined with microarray. A: Number of
differential expressed genes (y-axis) per time point post infection (x-axis). B: Hierarchical clustering by 2419 features (Pearson r, Ward’s method)
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Table 3 Examples of immune genes that responded to the functional feeds
Genbank Or Probename Gene, Symbol 0 wpc 6 wpc 8 wpc 14 wpc
CMS1 CMS2 CMS1 CMS2 CMS1 CMS2 CMS1 CMS2
Antiviral responses
BQ035726 Very large inducible GTPase 1-3, vlig −3.71 −1.87 −1.30 −2.75 −3.53 −4.80 −1.51 −3.71
? IFN inducible mx protein −5.37 −2.61 1.23 0.78 −1.77 −4.04 −1.09 −1.08
DY741158 STAT2 −2.70 −4.19 1.26 1.03 1.06 −1.67 1.20 1.08
CB500614 Pyrin, bty −1.38 −2.76 1.12 −1.03 −2.39 −3.50 −1.79 −1.14
BX909789 IRF4 2.82 2.64 3.28 1.46 −1.73 −2.14 1.31 −1.06
213061919 IRF7 3.33 4.43 −1.01 −1.19 1.54 −1.18 1.27 1.45
DW538275 Receptor-transporting protein 3 −1.90 −2.31 −0.09 −0.43 −0.85 −1.17 0.45 −0.13
T cells
Ssa#TC108524 MHC class I antigen −2.33 −1.57 −0.36 −1.02 −0.05 −0.34 −0.33 −0.52
? IFNg −1.66 −1.09 −2.18 −1.98 −2.44 −1.99 −1.32 −1.91
AY693394 CD8 beta 1.19 −1.35 −2.07 −1.76 −2.02 −1.43 −1.60 −1.74
CA368982 Kidney injury molecule 1, havcr1 1.36 −1.31 −1.46 −1.64 −4.27 −2.62 −1.36 1.19
DY710412 Granzyme A-1, graa −2.24 1.30 −2.65 −2.18 −3.04 −2.94 −1.04 −2.07
? Granzyme A-2, graa −1.48 −1.11 −2.76 −3.27 −3.56 −2.50 −1.19 −2.61
CR369847 NF activated T-cells calcineurin-dependent 1, nfatc1 −1.10 2.27 −1.63 −1.03 4.62 3.09 −1.88 −1.35
Inflammatory markers, regulators
213077403 TNF alpha-induced protein 2, tnfaip2 2.53 2.48 −3.51 −1.35 −2.53 −2.29 2.03 1.11
EG871595 c3a anaphylatoxin chemotactic receptor, c3ar1 −1.02 1.53 1.12 1.13 −2.53 −1.84 −1.17 −1.77
DW576911 Cytochrome P450 family 2 subfamily V, cyp2u1 −1.90 1.13 −5.38 −2.73 −1.74 −2.67 −2.35 −1.54
213081824 FcRgamma-like protein, fcer1g −6.40 −3.06 −2.44 1.16 −3.18 −2.05 1.20 −2.59
EG881931 TNF decoy receptor, tnfrsf6b 1.36 1.13 −1.73 −1.69 −2.96 −3.18 1.21 −1.10
213081931 Helicase lymphoid-specific, hells 2.24 4.47 1.34 2.20 −2.25 −1.98 −1.06 1.41
CK888744 fetuin B 1.16 1.39 0.87 1.19 1.42 0.58 1.51 −0.56
S48406409 Ly75/CD205 2.79 2.75 −1.13 −1.31 2.06 1.55 −1.27 −1.34
Data are expression ratios (fold changes) of fish fed the functional feeds (CMS1 and CMS2) relative to the REF diet during the course of the infection.
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http://www.biomedcentral.com/1471-2164/15/462modifying signalling pathways and stimulating immune-
related nuclear transcription factors (PPARs and NFkβ)
and the production of cytokines [15]. The n-6 LC-PUFA,
ARA, is associated with pro-inflammatory responses as
the precursor of pro-inflammatory eicosanoids, and EPA,
as well as being the precursor of anti-inflammatory eicosa-
noids, can also decrease the production of ARA-derived
eicosanoids through competition for the eicosanoid-
synthesising enzymes. DHA has also an anti-inflammatory
role in humans, particularly relevant at the recovery
phase of an inflammatory process, as it is a precursor of
immune-resolving resolvins and protectins [31].
Although macrophages, primarily produced in the head
kidney of fish, are a major source of eicosanoids, produc-
tion of eicosanoids at the site of the infection (e.g. heart
in CMS) is also highly relevant due to the short life of
these LC-PUFA derivatives [38]. As previously reported
in unchallenged [36] and challenged fish [25], DHA levels
in heart tissue PL did not reflect dietary levels, being gen-
erally similar in fish fed the three diets in the presentstudy. This may reflect the fundamental role of DHA in
the maintenance of cellular membrane structure and flu-
idity [39]. In our previous study investigating the effects
of similar diets on HSMI, levels of DHA were not signifi-
cantly affected during the time-course of the infection
after challenge with ASRV [25]. In contrast, the levels of
DHA in heart tissue PL changed significantly over the
time-course of the infection after PMCV challenge.
Levels of DHA were higher when there was enhanced
immune response and the heart lesions were more prom-
inent. Whether DHA levels were related with the activa-
tion of immune pathways involved in the control of the
inflammatory process requires further investigation in
fish. However, the present results suggest that changes in
the levels of DHA may be associated with PMCV infec-
tion and therefore this fatty acid could have a role in the
immune response in fish as has been described in
humans [31]. The associations between levels of ARA,
EPA and DHA in heart PL, the extent of heart histo-
logical lesions, and cardiac expression of genes related to
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Figure 7 Effect of the two functional feeds on immune gene expression in heart tissue of Atlantic salmon pre (week 0) and post
(weeks 6, 8, 14) PMCV infection, as examined with microarray. Data are log2 expression ratios between functional feeds (CMS1 and 2, noted
respectively as -1 and -2 after each time points) and reference feed (REF). Boxes show median values (total number of features for each pathway
indicated in panel header) with the 25th (dark grey) and 75th (light gray) percentile, and whiskers indicating minimum and maximum values.
Letters indicate significant differences between time points (p < 0.05, Student t-test).
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http://www.biomedcentral.com/1471-2164/15/462the immune response, indicated that dietary effects on
incorporation of LC-PUFA into cell membranes of af-
fected tissues could have important immunomodulatory
roles in viral infections.
The relevance of dietary supplementation with EPA
was supported when evaluating the expression of a key
enzyme of LC-PUFA biosynthesis, delta-6 fatty acyl
desaturase over the course of the infection. Higher ex-
pression of this enzyme and potentially higher biosyn-
thesis of n-3 LC-PUFA was reported previously in liverFigure 8 Expression between functional feeds (CMS1 and CMS2) and
signalling pathway. At cut off log2-ER = 0.8 (1.75-fold). Red/orange colour
indicates lower expression.of fish fed similar functional feeds compared with fish
fed a reference diet [25], later linked to dietary lipid/en-
ergy levels [40]. However, the present study is the first to
report a generally decreased expression of this enzyme
in all dietary groups over the course of PMCV infection
after 6-wpc, possibly indicating a negative effect of the
viral infection on LC-PUFA biosynthesis. This highlights
the importance of dietary supplementation of anti-
inflammatory n-3 LC-PUFA when fish are suffering viral
heart disease although further studies are required.reference diet (REF) of genes related with phosphatidyl inositol
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P-value PreCh 6 wpc 8 wpc 14 wpc 
time CMS1-REF CMS2-REF CMS1-REF CMS2-REF CMS1-REF CMS2-REF CMS1-REF CMS2-REF
Salmo salar delta-6 fatty acyl desaturase (Fadsd6) 8.41E-09 0.66 0.33 1.27 1.73 0.05 0.37 -1.29 0.82
Salmo salar delta-6 fatty acyl desaturase (Fadsd6) gene 4.44E-09 1.01 -0.45 2.65 2.54 0.52 0.16 -0.94 -0.09
Salmo salar delta-6 fatty acyl desaturase (Fadsd6) gene 4.57E-10 0.47 0.05 1.81 1.74 -0.08 1.27 -1.33 0.36
Delta-6 fatty acyl desaturase D6fad_a 2.00E-04 1.00 -1.90 1.53 2.06 1.16 -0.36 -0.61 0.10
Salmo salar delta-6 fatty acyl desaturase (Fadsd6) gene 2.18E-06 -1.12 -0.82 0.88 1.98 -0.33 -0.77 -2.13 -2.09
B
A
Figure 9 Expression of fatty acyl desaturase (Fadsd6) gene. A) Normalized expression of different probes of the oligoarray from delta-6 fatty
acyl desaturase (Fadsd6) gene over the time course of the PMCV infection on fish fed with the REF diet and the functional feeds (CMS1 and
CMS2). B) Expression ratios (fold changes) of different probes of the oligoarray from delta-6 fatty acyl desaturase (Fadsd6) gene. Data are fish fed
the functional feeds (CMS1 and CMS2) relative to the REF diet during the course of the infection. Red/orange colour intensity indicates higher
expression and green/blue colour intensity indicates lower expression.
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http://www.biomedcentral.com/1471-2164/15/462In addition to fatty acid composition, the PL class com-
position was also affected during viral infection, with de-
creased proportions of PI and PS as the infection
progressed. Phosphorylated derivatives of PI such as
phosphatidylinositol 4,5-bisphosphate (PIP2) are involved
in the production of the intracellular second messengers
diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3)
through the action of the phospholipase C [17]. DAG
and IP3 activate calcium channels, increasing Ca
+2 con-
centration in the cytosol, with this being an essential step
for the survival of some human viruses [41]. PS has also
been related with this signalling pathway as it is an im-
portant activator of protein kinase C [42,43]. The differ-
ence in expression of genes related with PI signalling
between the dietary groups along with decreased propor-
tions of PI and PS, suggested relevance of this pathway
during the infection, and could reflect utilization of these
PL classes associated with an immunomodulatory role.
This is a novel finding and the composition/content of
specific PL classes could be an interesting area for future
studies on clinical nutrition in fish.
Diet alone had marked effects on the cardiac expres-
sion of immune genes prior to challenge with functional
feeds suppressing genes related with innate antiviral re-
sponses and even those specific for lymphocytes. Broadly
similar effects were recently reported in a trial investigat-
ing substitution of dietary FO with VO in salmon [44]. Inthat study, expression levels of immune-related genes in
liver of fish fed a FO diet, with a fatty acid composition
similar to the functional feeds, were generally lower than
in fish fed a VO diet, with a composition similar to the
present REF diet. However, in the earlier study, genes re-
lated with the T-cell response were expressed at a lower
level in fish fed the VO diet [44]. This may be explained
by the higher levels of EPA present in the functional
feeds used in the present study compared with the FO
diet used in the earlier study, as the influence of EPA in
controlling T-cell signalling pathways has been docu-
mented previously [15,18]. Expression of genes related
with non-specific immune responses were also higher in
grouper (Epinephelus malabaricus) fed a VO/FO blend
compared with fish fed FO alone [37]. So it appears that,
even without any apparent infection, inclusion of FO
could dampen both innate and adaptive immune re-
sponses in fish. Thus, the generally higher immune status
of the fish fed the REF diet could be a factor in the earlier
development of inflammation and heart lesions associ-
ated with CMS in these fish compared with the fish fed
the functional feeds. Put another way, the functional
feeds generally lowered the immune/inflammatory status
prior to viral challenge and, in doing so, delayed and
moderated the response to the infection. This was sup-
ported by the recent finding that showed low-responder
fish to CMS, which developed high infection levels in the
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http://www.biomedcentral.com/1471-2164/15/462absence of cardiac pathology, had ablated expression of
adaptive immunity genes and genes involved in T cell re-
sponses [11]. However, it must be emphasised that immune
and inflammatory responses are essential components of
the host defence against infections [45]. Therefore, strat-
egies modulating the inflammatory response must be a bal-
ance between promoting resolution and mitigating negative
effects of chronic inflammation that can lead to damaging
fibrosis without preventing the initial onset of the response
[31].
Interestingly, IFN regulatory factors 4 and 7 were
among the few innate antiviral genes that were induced
by the functional feeds prior to infection. While IRF7
presumably is an important regulator of the antiviral IFN
response in fish, as in mammals [46], the suggested role
of IRF4 as a negative regulator of TLR signalling and
pro-inflammatory cytokines in mice peritoneal macro-
phages [47] is interesting in view of the down-regulated
antiviral state pre-challenge of fish fed the functional
feeds and hence the possible implications for the positive
effects post-infection. Whether IRF4 has a similar func-
tion in fish has yet to be confirmed.
The time-courses for the development and resolution
of histopathology and immune gene responses were simi-
lar to those observed previously [10,11]. In addition,
there were correlations between the expression of genes
related with immune responses, viral load and heart le-
sions, in agreement with Timmerhaus et al. [10]. Import-
antly, however, the temporal differences observed
between the different dietary treatments in the present
study strengthened these correlations. Thus, the changes
in the progression of CMS heart pathology, gene expres-
sion and viral load, in fish fed the REF diet were tempor-
ally similar to the development of the infection described
previously [10], whereas there was a clear delay in the ap-
pearance of those changes in fish fed the functional feeds.
Although viral load was not monitored at later stages of
the PMCV infection, the aforementioned correlation be-
tween histopathology and gene expression in the REF
group allow us to hypothesize that viral load in fish fed
the functional feeds would be higher at the later stages.
Therefore, the lower viral load in heart of fish fed the
functional feeds at early stages of PMCV infection was
probably a direct effect of diet on initial viral replication
as reported previously after ASRV infection [25]. Further-
more, in addition to a delay in the appearance of heart
pathology in fish fed the functional feeds, a slightly im-
proved performance of fish fed the CMS2 diet was ob-
served, which could be associated with reduced
expression of genes associated with the innate immune
response.
At 6-wpc, gene expression and heart tissue histopath-
ology of fish fed the REF diet were in agreement with
those reported previously [10]. Thus, atrium was affectedby the infection at 6-wpc with higher histoscores in fish
fed the REF diet compared to fish fed the functional
feeds, whereas ventricle was only slightly affected. A peak
in the expression of genes related with the complement
response, B and T-cell responses, and apoptosis was ex-
pected at this time post-infection [10], and many of the
genes related to these pathways showed lower expression
in fish fed the functional feeds compared to fish fed the
REF diet. In addition, genes related with antiviral and
interferon responses often showed higher expression in
fish fed the functional feeds compared with fish fed the
REF diet. The peak in expression of the latter genes was
reported to be at 2-4 wpc in the earlier study [10], sup-
porting the conclusion that there was a delayed response
in fish fed the functional feeds. A similar delayed re-
sponse to viral infection of around 2 weeks was observed
previously after ASRV infection in salmon fed functional
feeds [25].
As the CMS disease progressed the extent of lesions in
the heart increased in both atrium and ventricle with the
differences between the fish fed the functional feeds and
fish fed the REF diet being most pronounced at 8-wpc.
At this time-point, fish fed the functional feeds presented
lower histoscores in both atrium and ventricle compared
with fish fed the REF diet, which could be due to the up-
regulation of genes related with host immune response
observed at 6-wpc in fish fed the REF diet. At 8-wpc, fol-
lowing the hypothesis of delayed development of CMS in
fish fed the functional feeds, higher expression of genes
involved in antiviral and innate immune pathways could
have been expected in these fish compared with fish fed
the REF diet but, in contrast, these groups showed lower
activation of these pathways. Dietary modulation of the
inflammatory response has, of course, been described
previously in fish. Higher incorporation of n-3 LC-PUFA
in biological membranes of immune cells led to a lower
expression of pro-inflammatory cytokines in gilthead
seabream (Sparus aurata) [21], decreased antibody pro-
duction and macrophage killing activity in rainbow trout
[48], and lower production of pro-inflammatory eicosa-
noids in Atlantic salmon [19,20]. Furthermore, dietary
EPA suppressed production and release of TNF, interleu-
kins and IFN in humans [49]. Dietary EPA also sup-
pressed key components of the antiviral response in
gilthead sea bream, and dietary VO inclusion modulated
the expression of Mx proteins, interferon-induced media-
tors of innate resistance to RNA virus [50]. According to
these previous studies, the increased proportions of diet-
ary EPA in the functional feeds used in the present study
could be a factor in preventing an uncontrolled immune
response that could be more harmful to the fish.
As expected, many genes related with the T-cell re-
sponse showed lower expression in fish fed the func-
tional feeds compared with fish fed the REF diet [10].
Table 4 Formulation (g/Kg) and proximate composition
(percentage) of the reference (REF) and functional (CMS1
and CMS2) feeds
Component (g/100 g)1 REF CMS1 CMS2
Fish meal and hydrolysates 42.1 53.0 53.0
Plant protein concentrates2 21.5 18.0 18.0
Northern fish oil 13.0 0.0 0.0
Southern fish oil 0.0 10.0 10.0
Rapeseed oil 10.7 0.0 0.0
Carbohydrate-based binders3 11.9 11.9 12.1
Micro premixes4 0.8 1.7 1.9
Krill meal5 0.0 5.0 5.0
Histidine (synthetic) 0.0 0.4 0.0
Total 100 100 100
Proximate composition
Moisture 6.5 6.5 6.5
Fat 31.0 18.0 18.0
Protein 42.2 53.4 53.4
1) All ingredients sourced from EWOS stocks unless otherwise stated.
2) Includes soy protein concentrate, pea protein concentrate, wheat gluten and
sunflower meal.
3) Includes wheat grain.
4) Includes vitamins, minerals, crystalline amino acids, ammonium phosphate.
5) Aker Biomarine AS.
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http://www.biomedcentral.com/1471-2164/15/462Although gene expression was not assessed at 10- and
12-wpc, increased transcription of genes involved in virus
clearance may be predicted based on histopathology of
heart lesions at these time-points. By 14-wpc, there was a
clear remission in the lesions in both parts of the heart in
all dietary groups and therefore no significant differences
in the pathology were observed between them. Even
though the list of genes differentially expressed at 14-wpc
in fish fed the different diets was shorter than the ones
from previous sampling points, some pathways repre-
sented in the list of genes differentially expressed at 14-
wpc in fish fed the different diets could still indicate a
more effective remediation of the inflammatory response
by the group of fish fed with the functional feeds. Thus,
important markers of the T-cell response such as T cell re-
ceptor alpha, CD8 beta and alpha and CD82 antigen
showed lower expression in fish fed the functional feeds,
but expression of genes related with PI signalling was
higher in those fish compared with fish fed the REF diet.
As mentioned above, the PI signalling pathway is intim-
ately involved in the regulation of the T-cell response
[17], and dependent on the levels of membrane PL classes
and their fatty acid compositions. As the lesions in heart
tissue in CMS were associated with the action of CD8+
cytotoxic T-cells [10], factors controlling this response,
such as anti-inflammatory n-3 LC-PUFA, could be key to
the general better performance observed in the fish fed
the functional feeds. Furthermore, results from the previ-
ous study evaluating the use of functional feeds in salmon
infected with HSMI were consistent with this hypothesis.
Thus, milder expression of genes related with inflamma-
tory response and virus clearance, including those related
with T-cell response, were reported in salmon fed the
functional feeds leading to better performance of those
fish over the course of the HSMI infection [25].
Conclusions
The present study is the first to describe the effects of
functional feeds on the expression of genes related with
the immune response after infection of Atlantic salmon
with PMCV. Significant differences in immune and in-
flammatory responses and pathology in heart tissue were
found in fish fed the different dietary treatments over the
course of the infection, highlighting the potential immune
modulatory role of dietary fatty acid composition and lipid
content in viral infections in salmon. The strategy was ef-
fective in significantly reducing heart pathology and also
decreasing the time-course of the viral infection. Further-
more, liver pathology was significantly reduced during the
time course of the infection in fish fed the functional
feeds. Molecular signatures showed lower expression of
immune-inflammatory genes, especially those reported to
be correlated with heart lesions in the clinical phase (i.e. T
cells). Moreover, transcriptome analysis revealed a novelpathway of the fish immune response, the PI signalling
pathway, that functional feeds could modulate, as well as
potential suppression of LC-PUFA biosynthesis as the in-
fection progresses, stressing the importance of dietary
supplementation with n-3 LC-PUFA.
Methods
Experimental feeds and fish
Three fishmeal-based diets, based on a previous study in-
vestigating HSMI [25], were formulated and manufac-
tured by EWOS Innovation (Dirdal, Norway) (Table 4).
The reference diet (REF) was essentially a standard, com-
mercial formulation with 31% lipid with the added oil be-
ing a blend of Northern hemisphere FO and rapeseed oil.
The two functional feeds (CMS1 and CMS2) both con-
tained a lower level of lipid (18%) that was balanced by in-
creased protein, provided by fishmeal and krill meal.
Therefore, as a major factor differing between the REF
and functional feeds was dietary lipid level, the feeds were
not isolipidic or isoproteic. The added oil in the func-
tional feeds was provided by a Southern hemisphere FO.
As a result the CMS1 and CMS2 feeds had a similar fatty
acid profile containing higher proportions of EPA (almost
14%) and a n-3/n-6 PUFA ratio around 4, in comparison
to the REF feed (<4% EPA and an n-3/n-6 ratio of 1.4)
(Table 5). The only major difference between the func-
tional feeds was that CMS1 was supplemented with add-
itional histidine for reasons described above [30].
Table 5 Fatty acid compositions (percentage of total fatty
acids) of the reference (REF) and functional (CMS1 and
CMS2) feeds
Fatty acid REF CMS1 CMS2
Saturated 19.96 26.62 25.83
Mounsaturated 56.64 36.42 36.08
18:2n-6 8.38 4.94 5.55
20:3n-6 0.15 0.30 0.30
20:4n-6 0.18 0.64 0.66
n-6 PUFA 9.50 6.91 7.16
18:3n-3 3.11 1.27 1.31
20:5n-3 3.51 13.66 13.38
22:6n-3 4.77 8.41 8.45
n-3 PUFA 13.28 27.55 27.79
PUFA 23.40 36.97 38.09
n-3/n-6 1.40 3.98 3.88
EPA/ARA 19.35 21.40 20.20
% Lipid 25.60 17.30 16.46
ARA, Arachidonic acid; EPA, eicosapentaenoic acid; PUFA, polyunsaturated
fatty acids.
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moBreed IPN strain (average weight ca.150 g), were dis-
tributed into nine tanks (1 m3) at the VESO facility,
Vikan, Norway and fed one of the three feeds (3 tanks of
75 fish each per dietary treatment) for a period of
8 weeks prior to being transferred to the challenge tanks.
Feeding ration was a maximum of 2%. Seawater/brackish
water (ca. 25 ‰-35 ‰) delivery was flow-through suffi-
cient to maintain oxygen-satiation in effluent water 70%.
Water temperature was maintained at 12 ± 1°C, and a
photoperiod 24:0 h light/dark regime was followed.
Stocking density of the tanks was a maximum of 60 Kg/
m3. Feeding and infection challenge trials were approved
by The National Animal Research Authority (http://
www.fdu.no) according to the ‘European Convention for
the Protection of Vertebrate Animals used for Experi-
mental and other Scientific Purposes’ (EST 123).
Growth performance
Growth performance of fish was assessed using repeated
measurements of tank mean weights determined at the
start of the trial (day 0), challenge-day (day 92) and then
at 6-, 8-, 10-, 12- and 14-weeks post-challenge. A linear
mixed-effects (multilevel) model was fitted between the
response (weight) and predictor (diet) by allowing the
intercepts and slopes of the time variable (day) to vary
to account for tank level correlations and variability in
growth trajectories. The model was estimated with the
lmer function in the lme4 package of the R language (R
Development Core Team, 2008). All treatment effects
were based on posterior simulation (n = 2,500) with 95%credible intervals that were interpreted as statistical sig-
nificant (p = 0.05%) when the interval did not overlap
the reference value in question. There were no signifi-
cant differences in overall growth between dietary treat-
ments at the end of the trial (i.e. after 192 days)
(Additional file 2: Figure S1). However, after 92 days of
feeding (pre-challenge) fish fed diet CMS2 had higher
weights than those fed REF and CMS1 diets.
PMCV challenge
After the pre-feeding period, two fish from each pre-
challenge tank, 18 in total (n = 6 per dietary treatment)
were collected, as described below, prior to challenge (0
time-point) and the remaining fish were transferred to
challenge tanks (1 m3). The fish were unvaccinated and
tested for PMCV, ASRV, infectious pancreatic necrosis
virus (IPNV) and salmon pancreas disease virus (SPDV)
and confirmed as free from CMS, HSMI, IPN and PD.
Of the available salmon, a total of 600 fish, pre-challenge
average weight 479 ± 13 g for the fish fed with the REF
diet; 475 ± 13 g for the fish fed with the CMS1 diet and
502 ± 14 g for the fish fed with the CMS2 diet; were dis-
tributed into 12 tanks (4 tanks per dietary treatment
with 50 fish/tank). The fish were acclimated for 2 weeks
prior to challenge and were fed with the same diets dur-
ing the acclimation period and throughout the period of
the challenge (14 weeks) that they were fed prior to
transfer. No previous diseases were described. For chal-
lenge, the fish were sedated using Aqui-S at a final con-
centration of 5 mg/L of isoeugenol, followed by
anaesthesia in benzocaine (20%, Benzoak®) using a final
concentration of 30 ml/L. All 576 fish were challenged
by intramuscular injection of 0.1 ml PMCV inoculum on
each side of the fish in the lateral muscle tissue beneath
the dorsal fin (0.2 ml in total per fish). Production of the
PMCV inoculum was described previously [1]. Briefly,
the virus was originally isolated from heart tissue hom-
ogenate collected from a clinical outbreak of CMS and
filtered through a 0.22-μm filter. Challenge of Atlantic
salmon was performed using supernatant of GF-1 cell
culture in which the virus was inoculated.
Sampling
Ten fish from each tank (total of 40 per dietary treat-
ment) were sampled at 6-, 8-, 10-, 12- and 14-weeks
post-challenge. Fish were anaesthetized as above and
killed by a blow to the head and heart tissue collected for
analyses. Liver tissue and a portion of each heart were
transferred to 10% buffered formalin for histological ana-
lyses. Half of the remaining portions of heart tissue were
immediately transferred to RNAlater® (following manu-
facturers protocol) and later stored at -20°C prior to mo-
lecular analyses (i.e. 5 samples of heart tissue per tank, 20
per dietary treatment). The remaining portions of heart
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to lipid analyses (five per tank, 20 per treatment).
Histology
The histological changes in heart were assessed as de-
scribed in detail previously [1]. Briefly, the inflammatory
changes were evaluated separately for atrium and ven-
tricle, and to the extent present, inflammatory scores
of the epicardium were also recorded. In addition to
atrium and ventricle in the same sample, bulbus arterio-
sus was also included but not assessed for histopatho-
logical changes. Samples were fixed in 10% buffered
formalin, embedded in paraffin wax and sectioned at 3 -
4 micron and stained with hematoxylin and eosin ac-
cording to standard methods. All sections were evalu-
ated randomly and without knowledge to which feeding
group they belonged (double-blind).
Liver steatosis scores were ranked according to a
non-continuous score grade from 0 to 4 (Table 6).
Briefly, a score of 0-1 indicated lesions in the cyto-
plasm involving less than 10% of the hepatocytes and
including less than 25% of the area of the individual
hepatocytes, and low levels of leukocyte infiltration. A
score of 4 indicated lesions in the cytoplasm involving
more than 75% of the hepatocytes and including more
than 80% of the area of the individual hepatocytes, and
severe leukocyte infiltration. The initial “continuous”
scores were converted to a fewer number of discrete
scores (3 - 6 classes depending on the response).
Scores were an ordinal response and a multilevel or-
dinal regression was used to analyse the effects of feeds
on the scores. This was achieved with the ordinal pack-
age Sweave le processed by LATEX of the R language
(http://www.R-project.org). Each of the scores was
used as the response variable in separate analyses that
had feed type (REF, CMS1, CMS2) as the fixed effect
term. Since multiple fish were examined from each
replicate tank, a random effect of tank was added to
the model.Table 6 Scoring system for liver steatosis in individual section
Score Type of changes
0 No pathological findings or negligible nu
0.1-0.9 Increasing number of inflammatory cells
1 One or a few distinct focal lesions with c
1.1-1.9 Increasing number of lesion individually
2 Several distinct lesions and increased num
2.1-2.9 Multifocal myonecrosis with increasing n
3 Multifocal to confluent lesions and mode
3.1-3.9 Increasing number of foci towards diffus
4 Severe confluent lesions comprising >75
The changes observed by histological examination have been indicated on a visualLipid analyses
Lipid and fatty acid analyses were performed on heart tis-
sue from all sampling points. Three pre-challenge heart
samples per dietary treatment were randomly chosen for
lipid analysis. Heart tissue from the post-challenge sam-
ples was pooled per tank so that heart tissue of five fish
became a pool resulting in 4 pools/treatment/sampling
point. Total lipid from each pool was extracted according
to Folch et al. [51] by homogenization in chloroform/
methanol (2:1, v/v) containing 0.1% butylated hydroxyto-
luent (BHT) and lipid content determined gravimetrically.
Total lipid extracts were re-suspended in chloroform/
methanol at a concentration of 10 mg lipid/ml and stored
at -70oC until analysed. Phospholipid (PL) fractions were
prepared from 0.5 mg of total lipid by thin-layer chroma-
tography as described by Bell et al. [52]. FAME were sepa-
rated and quantified by GLC (Fisons 8160; Carlo Erba,
Milan, Italy) using a 60 m × 0.32 mm × 0.25 μm film
thickness capillary column (ZB-WAX; Phenomenex,
Macclesfield, Cheshire, UK) as also described previously
[52]. Tissue and diet lipid class compositions were deter-
mined by single-dimension double-development high-
performance thin-layer chromatography (HPTLC) and
densitometry as described previously [22]. Significance of
differences due to diet and time were determined by two-
way ANOVA (p < 0.05) using the SPSS 19.0 statistical
package (SPSS Inc., Chicago IL, USA).
Microarray experimental design
Heart tissue, as the main organ affected during a CMS
outbreak, was selected for transcriptomic analysis. The
choice of appropriate time-points for analysis was based
on the description of expression of genes of the immune
response after a PMCV infection described by Timmer-
haus et al. [10]. Thus samples from fish at pre-challenge,
6-, 8-, and 14- weeks post-challenge (wpc) were analyzed.
The pre-challenge sampling point was selected to evalu-
ate changes due to dietary compositions, and 6- and 8-
wpc sampling points were selected to evaluate dietarys
mber of inflammatory cells present.
per foci and moderate myocyte necrosis per foci.
ardiomyocyte necrosis, and distinct infiltration of leukocytes (1-5 per foci)
increasing in size per focus
ber of leukocytes
umber of inflammatory cells
rate to severe increase in number of leukocytes
e lesions. Inflammation increases as do endothelial hyperplasia.
% of the tissue and massive leukocyte infiltration
analog scale (0-4) based on the criteria given above.
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pathways at the peak of infection. As a plateau phase in
the expression of immune related genes at 10- and 12-
wpc was described previously [10], the 14-wpc sampling
point was selected to evaluate gene expression during the
recovery phase of the disease. Within each of these sam-
pling points, the available samples were arranged by indi-
vidual histoscore and 6 samples per dietary group were
randomly selected from the interquartile range (25 –
75%).
RNA extraction and purification
Heart tissue of the selected samples was homogenized in
TRI Reagent (Ambion, Applied Biosystems, Warrington,
U.K.) using an Ultra-Turrax homogenizer (Fisher Scien-
tific, Loughborough, U.K.). Total RNA was isolated fol-
lowing manufacturer’s instructions, and RNA quality
and quantity assessed by gel electrophoresis and spectro-
photometry (NanoDrop ND-1000, Thermo Scientific,
Wilmington, U.S.A.), respectively.
Microarray hybridisations and analysis
The transcriptomic experiment used an Atlantic salmon
custom-made oligoarray with 44 k features per array on a
four-array-per-slide format, with each feature printed sin-
gly (Agilent Technologies UK Ltd., Wokingham, UK). The
probes were co-designed by researchers at the Institute of
Aquaculture, University of Stirling, U.K. and Nofima (Ås,
Norway), and array design is available on request. A dual-
labelled experimental design was employed for the micro-
array hybridizations. Each experimental sample was com-
petitively hybridized against a common pooled-reference
sample, which comprised equal amounts of each of the
replicates used in the study. This design permits valid stat-
istical comparisons across all treatments to be made. The
entire experiment comprised 72 hybridizations; 4 time-
points (pre-challenge, 6-, 8- and 14-wpc) × 3 diets (REF,
CMS1 and CMS2) × 6 biological replicates.
Indirect labelling methodology was employed in prepar-
ing the microarray targets. Amplified antisense RNA
(aRNA) was produced from each RNA sample using the
TargetAmp™ 1-RoundAminoallyl-aRNA Amplification Kit
(Ambion, Applied Biosystems, Warrington, UK), follow-
ing the manufacturer’s methodology, followed by Cy3 or
Cy5 fluor incorporation through a dye-coupling reaction.
Briefly, 250 ng of total RNA per sample were amplified
and column-purified according to manufacturer’s instruc-
tions. Resultant aRNA was quantified and quality assessed
as above. Subsequently, Cy dye suspensions (Cy3 & Cy5)
in sufficient quantity for all labelling reactions were pre-
pared by adding 38 μL high purity dimethyl sulphoxide
(Stratagene, Agilent Technologies UK Ltd.) to each tube
of Cy dye (PA23001 or PA25001, GE Healthcare, Chalfont
St. Giles, UK). To attach the Cy dyes, 3 μg each aRNAsample was suspended in 10 μL nuclease-free H2O and
heated to 70°C for 2 min. When cooled to room
temperature, 3 μL of coupling buffer (0.5 M NaHCO3;
pH 9.2) and 2 μL of Cy3 dye suspension stock was added
and then incubated for 1 h at 25°C in the dark. To label
the common pooled reference sample with Cy5, a scaled-
up batch reaction was similarly performed. Unincorpor-
ated dye was removed by column purification (Illustra
AutoSeq G-50 spin columns; GE Healthcare). Dye incorp-
oration and aRNA yield were quantified by spectropho-
tometry (NanoDrop) and further quality controlled by
separating 0.4 μL of the sample on a thin mini-agarose gel
and visualizing products on a fluorescence scanner (Ty-
phoon Trio, GE Healthcare).
Hybridization of a total of 6 slides (24 arrays) was
performed in a single day, with sample order semi-
randomized, using SureHyb hybridisation chambers in a
DNA Microarray Hybridization Oven (Agilent Technolo-
gies) as described previously [25]. Scanning was performed
at 5 μm resolution using an Axon GenePix 4200AL Scan-
ner (MDS Analytical Technologies, Wokingham, Berk-
shire, U.K.). Laser power was kept constant (80%) and the
“auto PMT” function within the acquisition software (v.4)
was enabled to adjust PMT for each channel such that less
than 0.1% of features were saturated and that the mean in-
tensity ratio of the Cy3 and Cy5 signals was close to one.
Agilent Feature Extraction Software (v 9.5) was used to
identify features and extract fluorescence intensity values
from the resultant TIF images. The remaining analysis was
then performed in the GeneSpring GX version 12 analysis
platform (Agilent Technologies). After removing control
features and filtration of low quality spots (saturated, non-
uniform, population outliers and spots non-significantly
different from background), lowess normalization of log2-
expression ratios (ER) was performed.
As the primary objective of the present study was to
evaluate the effects of functional feeding (i.e. comparison
between diets), differentially expressed genes were se-
lected based on expression changes (cut off log2-ER =
0.8, 1.75-fold change, p < 0.05, one-way ANOVA) be-
tween the functional feed groups (CMS1 and CMS2)
and the fish fed the REF diet, or between the two func-
tional feed groups at each sampling point (pre-chal-
lenge-, 6-, 8- and 14-wpc). Annotation of selected genes
was performed using STARS software developed at
Nofima (Ås, Norway) [53], KEGG analysis, and informa-
tion from literature and public databases such as Gene
Expression Omnibus (GEO).
Validation of the microarray
Expression of 11 selected genes showing a significant
diet × time interaction in the microarray analysis at 2
different time points of the infection and related to
relevant immune-related pathways was studied by
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as previously described [25]. The qPCR primer sequences,
annealing temperature (Tm) and size of amplicon are
given in Additional file 3: Table S2. The sequences were
obtained either by literature searches or designed from
EST sequences corresponding to microarray clones or
candidate genes of interest using Primer3 software (http://
biotools.umassmed.edu/bioapps/primer3_www.cgi). Cofi-
lin-2 and elf-1α were used as reference genes as they were
sufficiently stable across treatments for normalization and
had been identified in previous salmon cDNA microarray
and qPCR studies as suitable reference genes on the basis
of constant expression between different feeds and time
points [44,54]. Data were analysed using the relative ex-
pression software tool (REST 2009, http://www.gene-
quantification.info/), which employs a pair-wise fixed re-
allocation randomization test (10,000 randomizations)
with efficiency correction, to determine the statistical sig-
nificance of expression ratios (or gene expression fold-
changes) between two treatments [55]. There was good
agreement between microarray results and RT-qPCR quan-
tification, with most of the comparisons showing identical
regulation and similar fold differences (Additional file 4:
Table S3). Analysis indicated that the gene expression data
obtained using the oligoarray were reliable and robust,
which enabled interpretations to be made with confidence,
especially with immune response-related genes.
Assessment of viral load
Relative quantification of PMCV by qPCR was used to
determine differences in the viral load between the diet-
ary treatments at the two critical points in the time-
course of the infection (6- and 8- weeks post-challenge)
when differential expression of genes related with the in-
flammatory process was greatest between fish fed the
REF diet and fish fed the functional feeds. The qPCR pri-
mer sequences (Additional file 3: Table S2) previously de-
scribed by Timmerhaus et al. [11] were employed
following the same procedure and from the same RNA
samples used for the validation of the microarray (as de-
scribed above).
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Additional file 1: Table S1. Gene expression pre-challenge, 6-, 8- and
14- weeks post challenge. Metabolic genes selected by significance
(one-way ANOVA at each time point) and expression differences between
the functional feeds (CMS1 and CMS2) and reference diet (REF) or between
CMS dietary groups. At cut-off log2-ER = 0.8 (1.75-fold). Red/orange colour
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Additional file 2: Figure S1. Growth performance over the course of
the entire trial, before and after the viral challenge. Error bars denote
approximate 95% confidence limits.
Additional file 3: Table S2. Primers used for the RT-qPCR.
Additional file 4: Table S3. RT-qPCR validation of microarray results.
Values represent the expression ratios for the selected genes between
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